Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $4,384 | $2,974 | $6,385 | $14,860 |
| - Cash | $149 | $2,274 | $3,053 | $27,622 |
| + Debt | $131 | $204 | $256 | $126 |
| Enterprise Value | $4,365 | $904 | $3,588 | -$12,636 |
| Revenue | $19 | $148 | $350 | $484 |
| % Growth | -87.4% | -57.8% | -27.6% | – |
| Gross Profit | $19 | $148 | -$21,094 | $484 |
| % Margin | 100% | 100% | -6,027.9% | 100% |
| EBITDA | -$11,766 | -$18,717 | -$29,576 | -$24,992 |
| % Margin | -63,171.7% | -12,663.2% | -8,451.7% | -5,167.7% |
| Net Income | -$7,437 | -$18,833 | -$29,774 | -$25,006 |
| % Margin | -39,929.3% | -12,741.6% | -8,508.3% | -5,170.5% |
| EPS Diluted | -11.35 | -145.12 | -1,203.05 | -2,507.83 |
| % Growth | 92.2% | 87.9% | 52% | – |
| Operating Cash Flow | -$8,608 | -$21,342 | -$27,687 | -$22,552 |
| Capital Expenditures | $0 | -$443 | -$896 | -$4 |
| Free Cash Flow | -$8,608 | -$21,785 | -$28,584 | -$22,556 |